Stocks · Health care · Pharmaceutical Preparations

NERVGEN PHARMA CORP.

NGEN Clue Score17
British Columbia, Canada Fiscal year ends December CIK 0001751912
1.73
-1.14%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
1.73 on 9 Oct 2026
6 4 2 Jan 2026 May 2026 Oct 2026 8 Jan 2026 $5.97 9 Jan 2026 $5.75 12 Jan 2026 $5.65 13 Jan 2026 $5.36 14 Jan 2026 $5.56 15 Jan 2026 $5.47 16 Jan 2026 $5.63 20 Jan 2026 $5.24 21 Jan 2026 $5.21 22 Jan 2026 $5.22 23 Jan 2026 $5.07 26 Jan 2026 $4.77 27 Jan 2026 $4.63 28 Jan 2026 $4.32 29 Jan 2026 $4.17 30 Jan 2026 $4.01 2 Feb 2026 $4.18 3 Feb 2026 $4.22 4 Feb 2026 $4.23 5 Feb 2026 $3.83 6 Feb 2026 $3.88 9 Feb 2026 $3.98 10 Feb 2026 $4.10 11 Feb 2026 $4.10 12 Feb 2026 $4.12 13 Feb 2026 $4.22 17 Feb 2026 $4.11 18 Feb 2026 $4.16 19 Feb 2026 $4.29 20 Feb 2026 $4.45 23 Feb 2026 $4.22 24 Feb 2026 $4.15 25 Feb 2026 $4.15 26 Feb 2026 $4.18 27 Feb 2026 $3.92 2 Mar 2026 $4.16 3 Mar 2026 $3.95 4 Mar 2026 $4.27 5 Mar 2026 $4.04 6 Mar 2026 $4.02 9 Mar 2026 $4.15 10 Mar 2026 $4.05 11 Mar 2026 $3.95 12 Mar 2026 $3.87 13 Mar 2026 $3.60 16 Mar 2026 $3.85 17 Mar 2026 $4.04 18 Mar 2026 $3.96 19 Mar 2026 $3.97 20 Mar 2026 $3.92 23 Mar 2026 $3.96 24 Mar 2026 $3.92 25 Mar 2026 $3.91 26 Mar 2026 $3.66 27 Mar 2026 $3.66 30 Mar 2026 $3.73 31 Mar 2026 $3.77 1 Apr 2026 $4.36 2 Apr 2026 $4.26 6 Apr 2026 $4.39 7 Apr 2026 $3.97 8 Apr 2026 $4.18 9 Apr 2026 $4.21 10 Apr 2026 $4.05 13 Apr 2026 $4.09 14 Apr 2026 $4.19 15 Apr 2026 $4.24 16 Apr 2026 $4.16 17 Apr 2026 $4.07 20 Apr 2026 $4.00 21 Apr 2026 $3.88 22 Apr 2026 $4.03 23 Apr 2026 $3.93 24 Apr 2026 $3.92 27 Apr 2026 $3.85 28 Apr 2026 $3.88 29 Apr 2026 $3.75 30 Apr 2026 $3.63 1 May 2026 $3.78 4 May 2026 $3.66 5 May 2026 $3.77 6 May 2026 $3.89 7 May 2026 $3.85 8 May 2026 $3.75 11 May 2026 $3.83 12 May 2026 $3.73 13 May 2026 $3.64 14 May 2026 $3.71 15 May 2026 $3.57 18 May 2026 $3.64 19 May 2026 $3.56 20 May 2026 $3.74 21 May 2026 $3.68 22 May 2026 $2.08 26 May 2026 $2.13 27 May 2026 $2.07 28 May 2026 $2.08 29 May 2026 $2.07 1 Jun 2026 $1.94 2 Jun 2026 $2.00 3 Jun 2026 $1.91 4 Jun 2026 $2.01 5 Jun 2026 $1.86 8 Jun 2026 $1.82 9 Jun 2026 $1.81 10 Jun 2026 $1.73 11 Jun 2026 $1.89 12 Jun 2026 $1.92 15 Jun 2026 $1.86 16 Jun 2026 $2.00 17 Jun 2026 $2.19 18 Jun 2026 $2.20 22 Jun 2026 $2.14 23 Jun 2026 $2.06 24 Jun 2026 $1.99 25 Jun 2026 $1.91 26 Jun 2026 $1.87 29 Jun 2026 $1.96 30 Jun 2026 $2.06 1 Jul 2026 $2.09 2 Jul 2026 $2.12 6 Jul 2026 $2.11 7 Jul 2026 $2.01 8 Jul 2026 $1.85 9 Jul 2026 $1.86 10 Jul 2026 $1.88 13 Jul 2026 $1.93 14 Jul 2026 $1.74 15 Jul 2026 $1.69 16 Jul 2026 $1.67 17 Jul 2026 $1.67 20 Jul 2026 $1.73 21 Jul 2026 $1.78 22 Jul 2026 $1.72 23 Jul 2026 $1.68 24 Jul 2026 $1.63 27 Jul 2026 $1.64 28 Jul 2026 $1.61 29 Jul 2026 $1.59 30 Jul 2026 $1.60 31 Jul 2026 $1.62 3 Aug 2026 $1.64 4 Aug 2026 $1.66 5 Aug 2026 $1.68 6 Aug 2026 $1.72 7 Aug 2026 $1.71 10 Aug 2026 $1.70 11 Aug 2026 $1.74 12 Aug 2026 $1.76 13 Aug 2026 $1.76 14 Aug 2026 $1.74 17 Aug 2026 $1.68 18 Aug 2026 $1.71 19 Aug 2026 $1.75 20 Aug 2026 $1.76 21 Aug 2026 $1.86 24 Aug 2026 $2.00 25 Aug 2026 $2.08 26 Aug 2026 $2.21 27 Aug 2026 $2.34 28 Aug 2026 $2.28 31 Aug 2026 $2.21 1 Sep 2026 $2.32 2 Sep 2026 $2.33 3 Sep 2026 $2.32 4 Sep 2026 $2.33 8 Sep 2026 $2.19 9 Sep 2026 $2.13 10 Sep 2026 $2.16 11 Sep 2026 $2.19 14 Sep 2026 $2.20 15 Sep 2026 $2.14 16 Sep 2026 $2.13 17 Sep 2026 $2.27 18 Sep 2026 $2.05 21 Sep 2026 $1.99 22 Sep 2026 $2.07 23 Sep 2026 $1.96 24 Sep 2026 $2.02 25 Sep 2026 $1.94 28 Sep 2026 $1.88 29 Sep 2026 $1.92 30 Sep 2026 $1.91 1 Oct 2026 $1.76 2 Oct 2026 $1.78 5 Oct 2026 $1.81 6 Oct 2026 $1.75 7 Oct 2026 $1.74 8 Oct 2026 $1.75 9 Oct 2026 $1.73
0 buys0 sales at will0 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Net income
$44.12M
Free cash flow
$19.50M
Return on equity
-1,268.9%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -24M FY24 Fiscal year 2024 Revenue $0.00 Net income $24.25M Margin n/a 0K -44M FY25 Fiscal year 2025 Revenue $0.00 Net income $44.12M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →

No open-market purchase or sale on file for this company.